Premium
Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome
Author(s) -
DARKE SHANE,
ROSS JOANNE,
MILLS KATHERINE,
TEESSON MAREE,
WILLIAMSON ANNA,
HAVARD ALYS
Publication year - 2010
Publication title -
drug and alcohol review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.018
H-Index - 74
eISSN - 1465-3362
pISSN - 0959-5236
DOI - 10.1111/j.1465-3362.2009.00101.x
Subject(s) - benzodiazepine , heroin , psychiatry , harm , medicine , psychology , harm reduction , public health , drug , social psychology , receptor , nursing
and Aims. Benzodiazepine use is associated with elevated levels of harm. The current study aimed to ascertain the long‐term nature of the relationship between benzodiazepine use and clinical profile among heroin users. Design and Methods. Longitudinal cohort, with follow‐up at 3, 12, 24 and 36 months. Participants were 615 heroin users recruited for the Australian Treatment Outcome Study. Results. At baseline, current benzodiazepine users were more likely to be committing crime, had poorer psychological health and poorer physical health. Baseline benzodiazepine use was not associated with the likelihood across follow‐up of heroin use ( P = 0.44), committing crime ( P = 0.17), poorer psychological health ( P = 0.31) or poorer physical health ( P = 0.48). Current benzodiazepine use was, however, associated with a greater likelihood of concurrent heroin use (OR 2.77), crime (OR 2.04), poorer psychological health (β = −4.47) and poorer physical health (β = −2.33). Discussion and Conclusions. Clinicians should be aware that reductions in benzodiazepine use are associated with reductions in harm, and that baseline benzodiazepine status does not equate to poor long‐term outcome . [Darke S, Ross J, Mills K, Teesson M, Williamson A, Havard A. Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome. Drug Alcohol Rev 2009]